IRIS
POMPILIO, ARIANNA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.842
EU - Europa 4.310
AS - Asia 3.743
SA - Sud America 422
AF - Africa 64
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 5
Totale 14.396
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.735
SG - Singapore 1.635
RU - Federazione Russa 1.095
CN - Cina 953
IT - Italia 731
IE - Irlanda 533
GB - Regno Unito 432
SE - Svezia 399
UA - Ucraina 395
BR - Brasile 338
VN - Vietnam 337
TR - Turchia 293
DE - Germania 212
FR - Francia 205
IN - India 172
FI - Finlandia 89
HK - Hong Kong 89
CA - Canada 54
JP - Giappone 44
BD - Bangladesh 41
ES - Italia 39
IQ - Iraq 39
MX - Messico 38
AT - Austria 34
NL - Olanda 34
PL - Polonia 28
AR - Argentina 26
ZA - Sudafrica 26
BE - Belgio 17
EC - Ecuador 16
KR - Corea 16
CH - Svizzera 15
VE - Venezuela 13
CZ - Repubblica Ceca 12
SA - Arabia Saudita 12
MA - Marocco 11
PK - Pakistan 11
CO - Colombia 10
ID - Indonesia 10
LB - Libano 10
UZ - Uzbekistan 10
IL - Israele 9
MY - Malesia 9
IR - Iran 8
EU - Europa 7
JO - Giordania 7
KE - Kenya 7
LT - Lituania 7
TH - Thailandia 7
PY - Paraguay 6
TN - Tunisia 6
AE - Emirati Arabi Uniti 5
CL - Cile 5
RS - Serbia 5
AZ - Azerbaigian 4
BY - Bielorussia 4
DK - Danimarca 4
GR - Grecia 4
PE - Perù 4
PH - Filippine 4
PT - Portogallo 4
UY - Uruguay 4
AO - Angola 3
CR - Costa Rica 3
DZ - Algeria 3
KZ - Kazakistan 3
NP - Nepal 3
OM - Oman 3
PA - Panama 3
SY - Repubblica araba siriana 3
AL - Albania 2
AU - Australia 2
BG - Bulgaria 2
BH - Bahrain 2
HN - Honduras 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
RO - Romania 2
SN - Senegal 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BZ - Belize 1
CG - Congo 1
CI - Costa d'Avorio 1
DO - Repubblica Dominicana 1
EE - Estonia 1
EG - Egitto 1
ET - Etiopia 1
GD - Grenada 1
GE - Georgia 1
HR - Croazia 1
JM - Giamaica 1
KW - Kuwait 1
LU - Lussemburgo 1
MD - Moldavia 1
MK - Macedonia 1
NG - Nigeria 1
NO - Norvegia 1
NR - Nauru 1
Totale 14.393
Salva come PNG Salva come JPEG
Città #
Singapore 1.216
Chandler 835
San Jose 621
Jacksonville 551
Dublin 527
Ashburn 430
Dallas 320
Dearborn 281
Beijing 268
Princeton 252
Southend 208
Chieti 162
Nanjing 150
Izmir 142
Los Angeles 141
Santa Clara 118
Wilmington 95
The Dalles 90
Ho Chi Minh City 89
Ann Arbor 79
Hong Kong 78
New York 78
Cambridge 74
Hanoi 70
Altamura 68
Buffalo 58
Tongling 58
Pescara 57
Moscow 53
Nanchang 48
Boardman 47
Council Bluffs 45
Dong Ket 42
Munich 41
Redondo Beach 41
São Paulo 41
Washington 39
Orem 34
Rome 33
Tokyo 33
Vienna 30
Kunming 27
Hebei 25
Hefei 24
Montreal 24
Shenyang 24
Chicago 23
Milan 23
Warsaw 23
Chennai 22
Jiaxing 22
Norwalk 22
Amsterdam 21
Frankfurt am Main 21
Woodbridge 21
Brooklyn 20
Nuremberg 20
Tianjin 20
Da Nang 18
Johannesburg 18
Civitanova Marche 17
Atlanta 16
Brussels 16
Poplar 16
Stockholm 16
Ancona 15
Baghdad 15
Mexico City 15
Teramo 15
Houston 14
Mumbai 14
Phoenix 14
Ankara 13
Boston 13
Denver 13
Haiphong 13
Pune 13
Falls Church 12
San Francisco 12
Changsha 11
London 11
Shanghai 11
Toronto 11
Kocaeli 10
Palermo 10
Seattle 10
Augusta 9
Guangzhou 9
Helsinki 9
Manchester 9
Rio de Janeiro 9
Seoul 9
Varallo 9
Belo Horizonte 7
Columbus 7
Ferrara 7
Grevenbroich 7
Jinan 7
Kuala Lumpur 7
Nairobi 7
Totale 8.519
Salva come PNG Salva come JPEG
Nome #
Adhesion and biofilm formation by Staphylococcus aureus clinical isolates under conditions relevant to the host: Relationship with macrolide resistance and clonal lineages 804
Identification, antimicrobial resistance and molecular characterization of the human emerging pathogen Streptococcus gallolyticus subsp. pasteurianus 220
Attività battericida ed anti-biofilm di peptidi antimicrobici verso patogeni multi-resistenti isolati da pazienti con fibrosi cistica. 181
Fatal sepsis by Klebsiella pneumoniae in a patient with systemic lupus erythematosus: the importance of postmortem microbiological examination for the ex post diagnosis of infection. 167
An overview on streptococcus bovis/streptococcus equinus complex isolates: Identification to the species/subspecies level and antibiotic resistance 157
Cooperative pathogenicity in cystic fibrosis: Stenotrophomonas maltophilia modulates Pseudomonas aeruginosa virulence in mixed biofilm 156
Colonic adenoma-associated Escherichia coli express specific phenotypes 156
Adhesion to and biofilm formation on IB3-1 bronchial cells by Stenotrophomonas maltophilia isolates from cystic fibrosis patients. 150
Antibiotic resistance and biofilm in Stenotrophomonas maltophilia isolates from cystic fibrosis and non-cystic fibrosis patients 149
A novel biotechnology product for the degradation of biofilm-associated polysaccharides produced by Streptococcus mutans 146
Analisi proteomica del biofilm formato da un ceppo di Stenotrophomonas maltophilia isolato da fibrosi cistica. 145
Helicobacter pylori ATCC 43629/NCTC 11639 Outer Membrane Vesicles (OMVs) from Biofilm and Planktonic Phase Associated with Extracellular DNA (eDNA). 144
A new challenge in cystic fibrosis antimicrobial therapy: activity of electrochemically synthesized silver nanoparticles against planktonic and biofilm cells of bacterial pathogens 143
In vitro microbiology studies on a new peritoneal dialysis connector 140
Phylogenetic relationships, biofilm formation, motility, antibiotic resistance and extended virulence genotypes among Escherichia coli strains from women with community-onset primitive acute pyelonephritis 140
Peptide dendrimers as “lead compounds” for the treatment of chronic lung infections by Pseudomonas aeruginosa in cystic fibrosis patients: In vitro and in vivo studies 135
An overview of various typing methods for clinical epidemiology of the emerging pathogen Stenotrophomonas maltophilia. 133
Effect of levofloxacin on Stenotrophomonas maltophilia biofilm and its relationship with SmeDEF multidrug efflux pump expression under conditions relevant to the cystic fibrosis lung 133
Meticillin-heteroresistant Staphylococcus pasteuri from an apheresis platelet product 132
Characterization of biofilm formation by Myroides odoratimimus isolated from post-traumatic calcaneal recurrent ulcer in diabetic patient 130
Alterazione dei livelli tessutali di ioni metallici in un modello murino di infezione polmonare da Stenotrophomonas maltophilia. 129
In vitro and in vivo evaluation of BMAP-derived peptides for the treatment of cystic fibrosis-related pulmonary infections 129
Role of excessive inflammatory response to Stenotrophomonas maltophilia lung infection in DBA/2 mice and implications for cystic fibrosis. 128
Evaluation of antibacterial and antibiofilm mechanisms by usnic acid against methicillin-resistant Staphylococcus aureus 125
Microbial cooperation in cystic fibrosis: Stenotrophomonas maltophilia significantly modulates Pseudomonas aeruginosa virulence. 125
Identification, antimicrobial resistance and molecular characterization of the human emerging pathogen Streptococcus gallolyticus subsp pasteurianus 125
null 125
Normal breathing releases SARS-CoV-2 into the air 123
Anaerobiosi ed ambiente acido influenzano l’attività in vitro di colistina nei confronti del biofilm formato da ceppi di Pseudomonas aeruginosa isolati da pazienti affetti da fibrosi cistica. 122
Development of a nanocomposite membrane based on reduced graphene (r-GO) and zeolite 13X for the removal of metal ions with bactericidal actions 122
A cystic fibrosis child with lung function decline 121
Giving Drugs a Second Chance: Antibacterial and Antibiofilm Effects of Ciclopirox and Ribavirin against Cystic Fibrosis Pseudomonas aeruginosa Strains 121
New insights in Staphylococcus pseudintermedius pathogenicity: antibiotic-resistant biofilm formed by a human wound-associated strain. 120
Effect of environmental factors on biofilm formation by clinical Stenotrophomonas maltophilia strains. 119
In vitro and in vivo evaluation of BMAP-derived peptides for the treatment of cystic fibrosis-related pulmonary infections 119
Pan-azole-resistant Candida guilliermondii from a leukemia patient's silent funguria 118
Misidentification of ampicillin-sulbactam heteroresistance in Acinetobacter baumannii strains from ICU patients 117
Helicobacter pylori Outer Membrane Vesicles (OMVs) as DNA shuttles and structural components of biofilm EPS 117
Efficacy of phages and antibiotic-phage combinations against biofilm by Pseudomonas aeruginosa from cystic fibrosis patients 116
Effetto di concentrazioni sub-inibenti di moxifloxacina su Stenotrophomonas maltophilia isolati da fibrosi cistica 115
Evolution of Stenotrophomonas maltophilia in Cystic Fibrosis Lung over Chronic Infection: A Genomic and Phenotypic Population Study 115
Serum and mucosal cytokine profiles in patients with active Helicobacter pylori and ischemic heart disease: is their a relationship ? 114
Cell surface hydrophobicity, motility, and biofilm formation of Stenotrophomonas maltophilia clinical isolates. 113
Hafnia alvei from the farm to the delivery room 113
Risk of misidentification of Enterobacter aerogenes inducible cephalosporinases. 112
Exposure to extremely low-frequency magnetic field affects biofilm formation by cystic fibrosis pathogens 112
Determination of ciprofloxacin and levofloxacin in human sputum collected from cystic fibrosis patients using microextraction by packed sorbent-high performance liquid chromatography photodiode array detector 112
An antimicrobial bicyclic peptide from chemical space against multidrug resistant Gram-negative bacteria 112
Staphylococcus pasteuri bacteraemia in a patient with leukaemia. 111
In vitro bactericidal and antibiofilm activity of six antimicrobial peptides against multidrug-resistant pathogens from patients with cystic fibrosis. 110
Stenotrophomonas maltophilia Phenotypic and Genotypic Diversity during a 10-year Colonization in the Lungs of a Cystic Fibrosis Patient 110
Infection of recurrent calcaneal ulcer caused by a biofilm-producer Myroides odoratimimus strain. 110
Antibacterial and anti-biofilm effects of cathelicidin peptides against pathogens isolated from cystic fibrosis patients. 110
Subinhibitory concentrations ofmoxifloxacin decrease adhesion and biofilm formation of Stenotrophomonasmaltophilia from cystic fibrosis. 109
D-BMAP18 Antimicrobial Peptide Is Active In vitro, Resists to Pulmonary Proteases but Loses Its Activity in a Murine Model of Pseudomonas aeruginosa Lung Infection 109
In vitro activity of colistin against biofilm by Pseudomonas aeruginosa is significantly improved under "cystic fibrosis-like" physicochemical conditions 109
In vitro activity of levofloxacin against planktonic and biofilm Stenotrophomonas maltophilia lifestyles under conditions relevant to pulmonary infection in cystic fibrosis, and relationship with SmeDEF multidrug efflux pump expression 109
In vivo bacterial cooperation in cystic fibrosis: exposure to Stenotrophomonas maltophilia affects Pseudomonas aeruginosa virulence in murine model of acute lung infection. 108
In vitro activity of multi-branched peptides against planktonic and biofilm cells of Pseudomonas aeruginosa from cystic fibrosis patients. 107
Factors associated with adherence to and biofilm formation on polystyrene byStenotrophomonas maltophilia: the role of cell surface hydrophobicity and motility. 106
Isolation of colistin-resistant Hafnia alvei. 106
Antidiabetic “gliptins” affect biofilm formation by Streptococcus mutans 106
Disomeostasi cationica in un modello murino di infezione polmonare da Stenotrophomonas maltophilia 105
Myroides odoratimimus Forms Structurally Complex and Inherently Antibiotic-Resistant Biofilm in a Wound-Like in vitro Model. 105
Stenotrophomonas maltophilia mutant lacking flagella remains virulent in DBA/2N mice but is less efficient in stimulating TNF-α expression 104
Antimicrobial and antibiofilm activity of secondary metabolites of lichens against methicillin-resistant Staphylococcus aureus strains from cystic fibrosis patients. 103
An ultrathin film membrane based on a nano-channeled reduced graphene oxide with enhanced antibacterial properties 103
Eparina sodica stimola la formazione di biofilm da parte di Providencia stuartii. 102
V240H replacement, by site-directed mutagenesis, increases resistance toward carbapenems in TEM-149 ESBL producing E. coli. 101
Identification of CTX-M-15 and CTX-M-27 in Antibiotic-Resistant Gram-Negative Bacteria Isolated from Three Rivers Running in Central Italy 101
Stenotrophomonas maltophilia virulence and specific variations in trace elements during acute lung infection: implications in cystic fibrosis. 99
Determinazione di Ciprofloxacina e Levofloxacina in espettorato da pazienti affetti da fibrosis cistica mediante MEPS-HPLC-PDA 99
Clonal diversity, biofilm formation, and antimicrobial resistance among Stenotrophomonas maltophilia strains from cystic fibrosis and non-cystic fibrosis patients 99
Modulation of biofilm formation by Stenotrophomonas maltophilia during chronic lung infection in cystic fibrosis patients: a longitudinal population study 99
Electrochemically Synthesized Silver Nanoparticles Are Active Against Planktonic and Biofilm Cells of Pseudomonas aeruginosa and Other Cystic Fibrosis-Associated Bacterial Pathogens 98
Phenotypic and genotypic characterization of Stenotrophomonas maltophilia isolates from patients with cystic fibrosis: genome diversity, biofilm formation, and virulence. 98
Tuberculosis-like pneumonias by the aerobic actinomycetes Rhodococcus, Tsukamurella and Gordonia. 98
Potential novel therapeutic strategies in cystic fibrosis: antimicrobial and anti-biofilm activity of natural and designed α-helical peptides against Staphylococcus aureus, Pseudomonas aeruginosa, and Stenotrophomonas maltophilia. 96
Molecular genotyping, adhesion and biofilm formation in methicillin-resistant Staphylococcus aureus clinical strains. 95
New insights in Staphylococcus pseudintermedius pathogenicity: Antibiotic-resistant biofilm formation by a human wound-associated strain 95
Corynebacterium glucuronolyticum causing genitourinary tract infection: Case report and review of the literature 94
ONE-STEP DEPOSITION METHOD FOR THE SYNTHESIS OF A NANOCOMPOSITE MEMBRANE BASED ON REDUCED GRAPHENE OXIDE/ZEOLITE-A FOR ADSORPTION OF METAL IONS WITH ENHANCED ANTIBACTERIAL PROPERTIES 94
“Indirect pathogenicity” in cystic fibrosis during pulmonary exacerbations: Stenotrophomonas maltophilia modulates Pseudomonas aeruginosa virulence in a Galleria mellonella model. 94
Olive Pâté by Multi-Phase Decanter as Potential Source of Bioactive Compounds of Both Nutraceutical and Anticancer Effects 94
Toward optimization of antimicrobial peptides for the treatment of multidrug resistant infections in cystic fibrosis. 93
Patogenesi in fibrosi cistica: clearance di Stenotrophomonas maltophilia ed infiammazione in un modello murino di infezione polmonare. 92
Ruolo epidemiologico del biofilm in isolati di Stenotrophomonas maltophilia da pazienti con fibrosi cistica e da pazienti ricoverati in unità di terapia intensiva 92
Multidrug-resistant Geotrichum capitatum from a haematology ward. 91
SURFACOME CHANGES of METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS IN BACTERIAL GROWTH UNDERGOING USNIC TREATMENT BY PROTEOMIC APPROACH 91
Electrochemically synthesized silver nanoparticles are active against planktonic and biofilm cells of Pseudomonas aeruginosa and other cystic fibrosis-associated bacterial pathogens 91
Chloramphenicol and rifampin may be the only options against Stenotrophomonas maltophilia. A tale of a colonized bladder device in a patient with myelofibrosis. 90
Comparative evaluation of the Vitek-2 Compact and Phoenix systems for rapid identification and antibiotic susceptibility testing directly from blood cultures of Gram-negative and Gram-positive isolates. 90
Attvità antibatterica ed anti-biofilm del peptide P19(9/B) verso isolati multi-resistenti isolati da pazienti affetti da fibrosi cistica 89
Studio microbiologico in vitro su di un nuovo connettore per dialisi peritoneale 89
Growth control of adherent-invasive Escherichia coli (AIEC) by the predator bacteria Bdellovibrio bacteriovorus: a new therapeutic approach for Crohn’s disease patients 89
Evaluation of in vitro activity of ceftolozane-tazobactam compared to other antimicrobial agents against Pseudomonas aeruginosa isolates from cystic fibrosis patients 88
Individuation and evaluation of new bacteriophages for the treatment of cystic fibrosis biofilm-related lung infections caused by Pseudomonas aeruginosa. 88
Anti-inflammatory strategies to tackle Pseudomonas aeruginosa lung infections: exploring the potential of the antimicrobial peptide lin-SB056-1 and its dendrimeric derivative 88
Bioactive compounds: a goldmine for defining new strategies against pathogenic bacterial biofilms? 88
null 87
Totale 12.132
Salva come PNG Salva come JPEG
Categoria #
all - tutte 55.873
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.873
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021191 0 0 0 0 0 0 0 0 0 98 24 69
2021/2022828 27 39 31 121 60 22 35 62 85 20 94 232
2022/20232.073 179 270 156 248 184 384 105 152 254 25 83 33
2023/2024918 61 50 79 33 80 250 194 47 12 25 8 79
2024/20252.122 119 360 245 73 54 109 108 102 283 103 256 310
2025/20265.223 364 187 544 522 570 241 946 343 1.117 389 0 0
Totale 15.061